What Is an Incisional Wound Vac and How Does It Work?

An incisional wound vac is a portable negative-pressure device placed directly over a closed surgical incision to lower infection rates, reduce fluid buildup, and support healing. Unlike the traditional wound vac used on open wounds, this version works on incisions that have already been stitched or stapled shut. A large meta-analysis of 57 randomized trials found that incisional negative-pressure wound therapy (iNPWT) cut surgical site infections by roughly a third compared with standard dressings, though the benefit is strongest in patients already at elevated risk for wound problems.

How the Device Works

The basic setup is straightforward: a foam or gauze dressing sits over the closed incision, sealed beneath an adhesive drape. A small battery-powered pump draws air out through a tube, creating a low level of suction across the wound surface. Most devices operate in a range of −75 to −125 mm Hg, and surgeons typically leave them in place for four to seven days after the operation.¹ The pressure isn’t painful in most cases but is enough to produce several measurable effects on the tissue underneath.

Finite element modeling shows that the suction redistributes mechanical stress around the incision, cutting lateral tension by about half and shifting the stress pattern to resemble that of intact, uncut skin.² In practical terms, this means the wound edges are held together more firmly. Fluid and blood that would otherwise pool under the skin get actively pulled into the dressing, which reduces the soggy environment bacteria thrive in. Perfusion studies in post-bariatric surgery patients have shown that incisions under negative pressure had higher oxygen saturation in the tissue and stronger blood flow three days after surgery compared with standard dressings.³ Better oxygenation means the immune system can fight contamination more effectively and collagen formation can proceed without delay.

Infection Prevention Across Surgical Specialties

The strongest argument for an incisional wound vac is its ability to reduce surgical site infections (SSIs). A 2023 systematic review and meta-analysis pooling 57 randomized controlled trials with nearly 14,000 patients found that iNPWT lowered SSI risk to about two-thirds of what it would be with standard dressings, and the certainty of the evidence was rated high.⁴ That overall figure, though, hides a lot of variation depending on what kind of surgery you’re talking about and how risky the patient’s profile is.

In abdominal surgery, the data are particularly convincing when the procedure involves contaminated or emergency cases. A separate systematic review focused on abdominal operations confirmed that iNPWT significantly reduced SSI rates in high-risk populations, along with reductions in seroma formation and wound dehiscence, but also noted that some studies found no benefit in lower-risk procedures.⁵ That pattern repeats across specialties: the device earns its keep when the baseline risk of a wound complication is already substantial.

Ventral Hernia Repair and Abdominal Wall Reconstruction

Ventral hernia repair, especially when combined with mesh placement and complex abdominal wall reconstruction, is a high-stakes setting for wound healing. These incisions are often long, the tissue has frequently been operated on before, and the patients tend to carry multiple risk factors. Two separate meta-analyses of prophylactic negative pressure after open ventral hernia repair found that iNPWT cut SSI rates roughly in half and also lowered wound dehiscence and hernia recurrence.⁶⁷

When a panniculectomy (removal of the hanging skin-and-fat apron) is done at the same time as hernia repair, the risk of wound complications escalates sharply. A study of 134 patients undergoing combined abdominal wall reconstruction and panniculectomy found that wound complications dropped from about 36% with conventional dressings to about 16% with iNPWT, with superficial wound breakdown falling from roughly 20% to 3%. No patients in the iNPWT group required a return to the operating room for wound problems, compared with about 13% in the standard dressing group.⁸ In a separate study specifically tracking hernia recurrence, the rate was zero in the iNPWT group versus about 11% in the standard dressing group at roughly six months of follow-up.⁹

Joint Replacement Surgery

Hip and knee replacements are among the most common elective operations in the world, and an infection in a prosthetic joint is a catastrophic complication. The strongest clinical evidence for iNPWT in orthopaedics involves patients who are at high risk for prolonged wound drainage after arthroplasty.¹⁰ A meta-analysis of arthroplasty studies found that iNPWT significantly lowered the odds of wound complications, SSIs, and reoperations, while also slightly shortening hospital stays.¹¹

A randomized trial in routine primary hip and knee replacements showed that the iNPWT group had significantly less wound exudate at its peak and required fewer dressing changes during their hospital stay. Wound complications trended toward a four-fold reduction, though the trial was sized for drainage rather than complications as its primary endpoint.¹² For nursing staff, the reduction in dressing changes is a practical advantage: fewer opportunities for contamination and less disruption for the patient in those first days when movement is already limited.

Vascular and Groin Incisions

Groin incisions for vascular surgery have notoriously high wound complication rates, partly because the groin is a warm, moist area with plenty of bacteria and the patients often have peripheral vascular disease, diabetes, or both. The evidence here is mixed in an instructive way. One randomized trial found a significant reduction in wound complications and revision surgeries with iNPWT.¹³ But another trial at a different institution, while showing a trend toward fewer infections (14% versus 28% in the control group), did not reach statistical significance and concluded it could not confirm the device’s efficacy for reducing groin wound infections after vascular surgery.¹⁴ The conflicting results probably reflect differences in patient populations and surgical techniques between institutions. The trend across both trials still points in a favorable direction, but surgeons treating groin wounds can’t assume the same level of certainty as in, say, ventral hernia repair.

Where the Evidence Falls Flat

Not every surgical context produces a win for the incisional wound vac. The most notable negative result comes from cesarean delivery in obese women. A large JAMA trial randomized over 1,600 obese women to iNPWT or standard dressings after cesarean section and found essentially no difference: about 3.6% developed an infection in the negative-pressure group versus 3.4% in the standard dressing group.¹⁵ An earlier pilot study had suggested a benefit in morbidly obese women specifically, but the larger trial did not bear that out.¹⁶ The researchers explicitly concluded that the findings do not support routine use of iNPWT in this population.

Colorectal surgery offers another cautionary example. A single-center study of colorectal patients found that those who received the incisional wound vac actually had a higher rate of SSI than those with standard dressings, even after adjusting for risk factors. The association was stronger in patients who had a colostomy.¹⁷ This is a single retrospective study, and it’s possible that the sickest patients were the ones chosen for iNPWT in the first place (a classic selection bias problem). Still, it underscores that slapping a wound vac on every incision is not automatically an improvement. The broader systematic reviews that include colorectal data still show a net benefit, but the effect appears weaker and less reliable in this specialty than in abdominal wall reconstruction or orthopaedics.

Who Benefits Most

A multidisciplinary consensus panel identified patient and procedural risk factors that make iNPWT most worth considering. On the patient side, the factors include obesity, diabetes, tobacco use, immunosuppression, malnutrition, low albumin levels, and anticoagulation therapy. On the surgical side, the list includes long operative times, repeat surgeries, contaminated surgical fields, emergency operations, and complex abdominal wall reconstruction.¹⁸ An international multidisciplinary consensus separately recommended that surgeons assess the individual patient’s risk profile and consider iNPWT for those at high risk for complications or for procedures where an SSI would be especially damaging, such as implant-based surgery.¹⁹

The common thread is that the device delivers the most value when there’s already a meaningful baseline risk. If you’re a healthy, non-obese, non-diabetic patient having a clean elective procedure, the existing data doesn’t strongly support routine use. But if you check off two or three risk factors, the calculus shifts.

Skin Blistering and Other Side Effects

The most common adverse effect is skin blistering, particularly linear blisters that form at the edges of the foam dressing where the adhesive drape meets normal skin. A large meta-analysis reported that patients using iNPWT had roughly four and a half times the risk of skin blistering compared with standard dressings, with one blister-related complication occurring for roughly every 18 patients treated.²⁰ The same analysis found an even higher relative risk for device-related adverse events more broadly. In arthroplasty specifically, the blistering rate was also significantly elevated.²¹

The blisters appear to be a mechanical phenomenon rather than an allergic reaction. When the pump draws air from the sealed space under the drape, a small triangular gap between the foam edge, the skin surface, and the adhesive film creates a localized zone of extra suction. This pulls the epidermis apart from the layers beneath, and fluid fills the resulting pocket.²² Modified dressing techniques that fill or cushion this gap have been proposed to minimize the problem. For most patients, the blisters are a nuisance rather than a serious complication, but in patients with fragile skin (the elderly, those on long-term steroids), they can become a secondary wound concern.

Beyond blistering, patients report some practical annoyances. A qualitative study of people using negative-pressure devices found recurring themes of discomfort, physical limitation from being attached to the pump, noise from the motor, and the psychological burden of managing a medical device during recovery.²³ Most incisional wound vacs used today are small, single-use, battery-powered units that are far more portable than the older canister-based systems, but they still add a layer of complexity to daily life that a simple gauze dressing doesn’t.

Cost Considerations

An incisional wound vac unit typically costs several hundred dollars, which raises the obvious question of whether it saves money downstream. The answer depends almost entirely on how likely the patient is to get an infection without one. A cost-effectiveness analysis in elective colorectal surgery found that, standardized to 1,000 patients, prophylactic iNPWT prevented 51 infections, 10 incisional hernias, and 6 hospital readmissions while generating a net cost saving. The device became cost-effective once the patient’s baseline SSI risk exceeded about 3%.²⁴ A more recent analysis looking at superficial SSI prevention across various surgical settings put the threshold higher, at about 6.4%, but still found that over 95% of simulated scenarios favored iNPWT as the more effective strategy.²⁵

For cesarean sections in obese women, where the clinical trial found no infection benefit, the cost-effectiveness picture still looked favorable on paper: total costs per patient were slightly lower in the iNPWT group, and at standard willingness-to-pay thresholds the probability of the intervention being cost-effective was over 90%. However, the savings were mainly driven by the subgroup of women with a pre-pregnancy BMI of 35 or higher, and neither the cost difference nor the health outcome difference was statistically significant.²⁶ The takeaway is that the economics depend on the clinical context. In procedures where the device genuinely prevents infections, the math works out comfortably; in settings where it doesn’t change the infection rate, spending hundreds of dollars per patient on a device is harder to justify.

Does It Improve Scars?

Given that the device holds wound edges together and reduces lateral tension, you might expect better scars. The evidence here is genuinely mixed. A randomized trial that split each patient’s sternotomy incision into an iNPWT side and a standard-dressing side found no significant difference in scar width, pliability, redness, or pigmentation at any follow-up point.²⁷ On the other hand, a study of cosmetic suture wounds reported that the iNPWT group had significantly better scores on patient scar assessment and scar-height scales at one year.²⁸ A small randomized trial in forearm fracture patients found that those who received iNPWT were cosmetically satisfied with their scars and had favorable results on histological staining for collagen organization, though the differences did not reach statistical significance.²⁹

The discrepancy may come down to wound location and patient characteristics. Sternotomy scars sit over a relatively stable bony surface with little lateral tension, so the extra mechanical support of iNPWT may not add much. In areas where skin is under greater tension or where patients are prone to hypertrophic scarring, the device could provide a bigger marginal benefit. But at this point, nobody should choose an incisional wound vac primarily for cosmetic reasons; if better scarring happens, it’s a side benefit.

Use in Children and Neonates

Pediatric data are limited but cautiously encouraging. A study evaluating the safety and efficacy of incisional wound vac dressings in pediatric and neonatal surgical patients reported that the devices could be used safely and showed a trend toward lower SSI rates, though the sample size was not large enough to confirm a statistically significant benefit.³⁰ Children’s skin is thinner and more sensitive to adhesive trauma, so the blistering risk warrants attention. Neonates in particular require careful device sizing and monitoring. Most of the large trials and meta-analyses were conducted in adults, so pediatric surgeons are extrapolating from adult evidence more than they’d like, and practice varies widely between institutions.

Portable Single-Use Versus Traditional Canister Systems

The older style of wound vac uses a bulky canister that collects fluid and plugs into a wall outlet or large battery. These systems are still common for open wound management but are impractical over a simple closed incision. The newer portable, single-use devices are battery-powered, roughly the size of a small smartphone, and disposable. A randomized trial comparing a single-use system against a traditional canister-based system (albeit in chronic leg ulcers rather than closed incisions) found that the portable device produced faster wound-area reduction and a higher rate of wound closure, with fewer device-related adverse events.³¹ For incisional use specifically, single-use devices are now the norm because the wound doesn’t produce large volumes of fluid and the patient benefits from being able to move around without dragging equipment.

Common Misconceptions

One widespread misunderstanding is that an incisional wound vac is the same thing as the wound vac used on open, hard-to-heal ulcers. The open-wound version involves packing foam into a wound cavity and applying negative pressure to draw out infected tissue and stimulate granulation. The incisional version works on a completely different type of wound: one that has already been closed with sutures or staples. The goals are different, the pressures are often lower, and the expected duration is days rather than weeks.

Another misconception is that the device is appropriate for every surgical patient. As the cesarean and colorectal data show, the benefit is not universal. International consensus recommendations explicitly caution that surgeon judgment about individual risk factors should drive the decision, not a blanket protocol.³² Using the device on a low-risk patient adds cost and blistering risk without a demonstrated payoff.

Finally, some patients assume a wound vac means something went wrong during surgery. Hearing the word “vac” associated with their incision can trigger anxiety. In reality, the device is placed prophylactically at the end of an otherwise normal operation, specifically to keep things from going wrong. Framing it as a preventive dressing rather than a treatment for a problem helps patients understand what it is and why it’s there.